No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Male
Study type
Observational
Participants needed
575 (estimated)
Sponsor
University Health Network, Toronto · Other
Who this trial is looking for
This trial is looking for men with localized prostate cancer or those currently undergoing treatment. Participants will have access to online educational resources and sexual health counseling to help improve their sexual function and intimacy after treatment.
Are You a Good Fit for This Trial?
You may be able to join if
I am 18 years of age or older
I have been diagnosed with localized prostate cancer
I am currently receiving treatment for prostate cancer
I have received treatment for prostate cancer in the past 6 months
I have access to a computer or smartphone with internet
I am not currently receiving hormone or chemotherapy
You may not be able to join if
I am only receiving hormone therapy as treatment for prostate cancer
I lack proficiency in English
I am taking nitrate therapy
I have medical conditions that make sexual activity unsafe
I have received previous treatment for prostate cancer
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
The goal of this observational study is to evaluate the effectiveness of SHAReClinic, a national, virtual Sexual Health and Rehabilitation eClinic designed to support prostate cancer patients and their partners. Specifically, this study aims to assess SHAReClinic's impact on improving sexual function, satisfaction, and relational intimacy after treatment.
The primary objective is to evaluate SHAR…
The goal of this observational study is to evaluate the effectiveness of SHAReClinic, a national, virtual Sexual Health and Rehabilitation eClinic designed to support prostate cancer patients and their partners. Specifically, this study aims to assess SHAReClinic's impact on improving sexual function, satisfaction, and relational intimacy after treatment.
The primary objective is to evaluate SHAReClinic's effectiveness across participating sites and determine its role in supporting long-term sexual health and well-being.
As part of usual care, newly enrolled SHAReClinic patients will receive guided education modules and access to sexual health counselling at key recovery milestones.
SHAReClinic seeks to expand access to sexual health care for prostate cancer patients across Canada by providing evidence-based, virtual sexual rehabilitation. Findings from this study will inform best practices in survivorship care and contribute to the development of a national standard for oncology sexual health interventions.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Patients who are scheduled for first-line treatment for localized prostate cancer, either through radical prostatectomy (open or robotic) or radiation treatment (brachytherapy, external beam) Alone, or with adjuvant Androgen Deprivation Therapy (ADT) OR
* Patients currently…
Inclusion Criteria:
* Patients who are scheduled for first-line treatment for localized prostate cancer, either through radical prostatectomy (open or robotic) or radiation treatment (brachytherapy, external beam) Alone, or with adjuvant Androgen Deprivation Therapy (ADT) OR
* Patients currently undergoing active treatment for prostate cancer OR
* Patients who have undergone cancer treatment in the past 6 months
* Patients who are hormone and/or chemotherapy-naïve
* Patients who have access to a computer or smartphone with internet access
* Patients who are 18 years of age or older
Exclusion Criteria:
* Patients on ADT alone as primary treatment, and/or patients on chemotherapy
* Patients who lack English proficiency
* Patients on nitrate therapy or have other contra-indications to phosphodiesterase type 5 inhibitors (PDE5i's)
* Patients with medical conditions that would preclude safe sexual activity
* Patients who have had previous treatment for PCa
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.
